Tovinontrine not checked

Imara, Inc. · Cardurion Pharmaceuticals, Inc. · IMR-687

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
None yet
 
Trials
1 active
8 in total · 2 in the EU
Targets
 

What this is

How it works
How it works isn't classified yet
Tested for
Sickle Cell Disease
Main trialPhase 2
“This is an open-label extension study of IMR-687 in adult patients who completed Imara's blinded Phase 2a study (IMR-SCD-102). The open-label extension study will evaluate long-term safety and tolerability.”In the company’s words, NCT04053803 on ClinicalTrials.gov
Other names
IMR-687

Other drugs for Sickle Cell Disease

All 21 drugs for Sickle Cell Disease

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials8

TrialPhaseCompletesWhat it tests
Phase 2Active, not recruiting Mar 2025 An Extension Study of IMR-687 in Adult Patients With Sickle Cell Anemia
Phase 2Completed 28 Aug 2020 A Study of IMR-687 in Adult Participants With Sickle Cell Anemia (Homozygous HbSS or Sickle-β0 Thalassemia)
Phase 2Terminated 2 Mar 2022 A Study of IMR-687 in Subjects With Sickle Cell Disease
Phase 2Terminated 11 Mar 2022 A Study of IMR-687 in Subjects With Beta Thalassemia
Phase 2Withdrawn Sep 2023 Selective PDE9 Inhibition With IMR-687 in Adults With Heart Failure With Preserved Ejection Fraction
Phase 2Completed 2 Sep 2025 Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Preserved Ejection Fraction (Cycle-2-PEF)
Phase 2Completed 10 Oct 2025 A Study to Assess Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Reduced Ejection Fraction (Cycle-1-REF)
Phase 1Completed 8 Jul 2017 A Study of IMR-687 in Healthy Adult Volunteers
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 20 Nov 2026 · EU trials register (CTIS) updated 20 Nov 2026 · openFDA updated 20 Nov 2026

Follow Tovinontrine

Following is part of Solo: you see every change to Tovinontrine the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in